United States: Market and legal data for the cannabis sector

How might newly elected US governors approach cannabis laws in their states?

Written by Freddie Dawson | 19th November 2024

Not a single US state governorship flipped parties during the elections held on 5th November despite strong gains in the Senate for the Republican party, as well as the party’s victory in the presidential election...

US cannabis industry has high hopes for itself under a second Trump presidency

Written by Tiziana Cauli | 19th November 2024

While the sector’s optimism about the prospect of a Republican presidency would have barely been imaginable until recently, Donald Trump’s re-election is being welcomed with positive expectations by the country’s cannabis industry ...

Is another Donald Trump administration bad news for the US cannabis industry?

Written by Tiziana Cauli | 14th November 2024

Until last week, the US cannabis sector was wondering what to expect from the then-upcoming presidential elections, and cannabis legalisation was also on the ballot in several states ...

UK NHS study first to test CBD and THC drugs together in treatment of epilepsy

Written by Tiziana Cauli | 30th October 2024

Two CBD- and THC-based drugs to treat child epilepsy will be tested on 500 patients countrywide in the UK next year in a trial by researchers at University College London and Great Ormond Street Hospital...

Cannabis and the US elections: from Schedule I drug to business prospect

Written by Tiziana Cauli | 17th October 2024

As the US cannabis sector prepares for the economic impact of an announced reclassification of marijuana to a less-restrictive schedule, the presidential contest seems to have already turned cannabis into a business opportunity worth supporting...

Using after 50: US poll reveals cannabis consumption trends among older adults

Written by Tiziana Cauli | 25th September 2024

One in five older adults in the US use cannabis for recreational or medical reasons, based on a recent survey. Besides risks related to use without medical advice, researchers identified some hazardous behaviours ...

Would the US Supreme Court overturn the decision on the legality of THCO?

Written by Freddie Dawson | 19th September 2024

The US Fourth Circuit Court of Appeals recently decided tetrahydrocannabinol acetate (THCO) was legal under current federal law, disregarding an interpretation by the Drug Enforcement Administration ...

IHDCs are legal under US federal law, according to appeals court case ruling

Written by Freddie Dawson | 16th September 2024

A US federal circuit appeals court has affirmed the legality of “synthetically derived” hemp cannabinoids, rejecting interpretations by the Drug Enforcement Administration (DEA) on intoxicating hemp-derived cannabinoids (IHDCs) in the process ...

From US state to federal government, is Kamala Harris a cannabis friend or foe?

Written by Freddie Dawson | 9th September 2024

Democratic US presidential candidate Kamala Harris has become one of the most positive major voices for cannabis liberalisation at the federal level, but critics say her prior record undermines that and leaves her untrustworthy ...

Prior to US elections, Trump talks the talk on cannabis, but has yet to walk the walk

Written by Frederick Dawson | 6th September 2024

Republican US presidential nominee Donald Trump may end up an ally of the cannabinoid industry if recent comments on his voting intentions are to be believed ...

Epidiolex misses trial’s efficacy goal in Japan as it aims for drug authorisation

Written by Tiziana Cauli | 28th August 2024

Clinical trials on CBD-based medical drug Epidiolex missed their main goal of registering a significant reduction in the frequency of seizures experienced by patients in Japan, based on the results reported by manufacturer Jazz Pharmaceuticals...

Chief research officer shares equation for success in developing next-gen products

Written by CannIntelligence | 23rd August 2024

Businesses that lead product innovation with what the consumer wants will be one step ahead when it comes to taking a next-generation product to market – particularly when making PMTAs in the US ...

US Republican VP nominee may support cannabis regulation but not legalisation

Written by Freddie Dawson | 16th August 2024

Republican nominee for vice-president JD Vance has been silent on vaping, tobacco alternatives and the Ohio cannabis legalisation debate, but some of his comments suggest he may support the regulation of recreational cannabis ...

US Democratic VP nominee could be supportive of pro-cannabis policies

Written by Freddie Dawson | 12th August 2024

New Democratic nominee for vice president Tim Walz is unlikely to be an ally to the tobacco alternatives and vaping industries but, as governor of Minnesota, he was keen on legalising cannabis ...

Not your usual partnership between cannabinoid brand and vaping company

Written by Freddie Dawson | 9th August 2024

Vaping company Ispire has signed a 30-year global licensing agreement with Hidden Hills Club, a cannabinoid operation with wider lifestyle ambitions that will lead to the creation of Hidden Hills branded nicotine vaping products ...

As contests for US governorships ramp up, how do candidates view cannabis?

Written by Freddie Dawson | 25th July 2024

Though debate about US president Joe Biden’s potential replacement dominates headlines on the November elections, down-ballot races in many states may impact the future of cannabis in the country ...

Florida governor’s veto on IHDC ban bill: good news for hemp or playing politics?

Written by CannIntelligence | 3rd July 2024

Florida’s governor last month vetoed a bill that would have banned most intoxicating hemp-derived cannabinoid (IHDC) products and limited the amount of total delta-9 THC in hemp products ...

Red scare in the green game – should Chinese activity in US farming raise flags?

Written by Freddie Dawson | 27th June 2024

Revelations about Chinese activities in the US agriculture sector have raised a number of issues. Evidence of increased activity by Chinese national affiliates has sparked something of a red scare among commentators ...

Are US regulators far removed from society when it comes to cannabis?

Written by Tiziana Cauli | 29th May 2024

While moving cannabis to a less-restrictive Schedule III will not legalise the recreational market at a federal level, it may reflect the need for authorities to modify their attitude to align with changes in society...

Contamination and adulteration of vape products: how serious is the problem?

Written by CannIntelligence | 27th May 2024

The recent discovery of the illicit animal tranquilliser xylazine in cannabis vapes raises concerns about harmful contaminants. How do these substances end up in vaping products? ...

The long road to EFSA authorisation for CBD as novel food in the European Union

Written by Tiziana Cauli | 20th May 2024

In June 2022, the European Food Safety Authority broke some very bad news to CBD companies applying for their products to be authorised as novel food in the European Union ...

‘Revolutionary’ US cannabis rescheduling set to increase companies’ profitability

Written by Tiziana Cauli | 9th May 2024

The reclassification of cannabis to a less restrictive schedule of the US Controlled Substances Act will have crucial implications for the industry, especially as far as taxation is concerned, experts say ...

Germany’s cannabis law could open doors for foreign businesses to set up in Europe

Written by Tiziana Cauli | 23rd April 2024

As Germany becomes the first country in mainland Europe to partially legalise adult-use cannabis, investors from outside the continent may want to establish a presence in the European market now and wait for opportunities ...

The uncertain fate of IHDCs in Europe: could a general ban be on the horizon?

Written by Tiziana Cauli | 12th April 2024

In this part of a series of articles celebrating the tenth anniversary of Tamarind Intelligence, we look at how the landscape of intoxicating hemp-derived cannabinoids (IHDCs) across Europe has changed over the years ...

UNESCO declares CBD store in suburban US shopping mall a World Heritage Site

Written by CannIntelligence | 1st April 2024

CBDeelite has today (1st April) been declared a World Heritage Site by the United Nations Educational, Cultural and Scientific Organization (UNESCO), in an effort to preserve some of the CBD era for future generations ...

The rise of cannabis clubs in Europe – the grassroots model regulators are adopting

Written by Tiziana Cauli | 12th February 2024

The cannabis social club model is now being incorporated by multiple European regulators. Born and developed outside a legal framework, it originated as an attempt to regulate cannabis production and consumption ...

What’s in store for cannabis regulation? Looking at 2024 with cautious optimism

Written by Freddie Dawson | 10th January 2024

Cannabis rather than hemp will see the primary regulatory changes in 2024, CannIntelligence predicts, with moves coming in the US, Thailand, Germany and France, among others ...

22nd Century sells its hemp/cannabis business to cut debt and operating costs

Written by Freddie Dawson | 29th November 2023

US-based 22nd Century will sell its hemp/cannabis subsidiary, GVB Biopharma, to an entity affiliated with current GVB employees and will use the sale proceeds to pay off debt and further deleverage its balance sheet ...

Extension of Farm Bill coverage to 2024 means good news for the US hemp sector

Written by Tiziana Cauli | 27th November 2023

US hemp farmers will be able to continue operating under the 2018 Farm Bill framework until the end of September next year, as stopgap funding was approved and signed into law by president Joe Biden...

Weaker demand for hemp and cannabis products impacts 22nd Century’s revenue

Written by Freddie Dawson | 7th November 2023

22nd Century reported decreased revenues for the third quarter of 2023 and blamed demand challenges in its hemp/cannabis product distribution business, although this still represents the biggest part of its net revenue ...

CBD regulatory progress in US Congress grinds to a halt in partisan gridlock

Written by CannIntelligence | 18th October 2023

Partisan gridlock continues to keep Congress from clarifying the regulatory framework for CBD. Even as the Biden administration moves to reschedule cannabis, Congress punts CBD issues back and forth with the FDA ...

US cannabis industry has ‘lost its shine’, but easing taxes may re-attract investors

Written by Lorraine Mullaney | 2nd October 2023

Stakeholders are feeling more optimistic that relief could be on its way for the US cannabis industry, which is currently struggling ...

Study finds US cannabis sector in crisis, but possible rescheduling offers hope

Written by CannIntelligence | 2nd October 2023

US cannabis rescheduling could eventually lead to companies saving around $2bn a year in federal taxes, a recent cannabis economics report claims, by allowing businesses to deduct their business expenses on their federal tax returns...

Struggling industry blames FDA as Canadian companies leave US market

Written by CannIntelligence | 7th September 2023

Another major Canadian cannabinoid company is leaving the US market amid concerns over the regulatory environment some say the US Food and Drug Administration has caused ...

US scheduling recommendation could bring big boost to cannabis industry

Written by Anthony Traurig | 1st September 2023

The US Department of Health and Human Services recommendation to reschedule cannabis to a less restrictive schedule could be the boon that the besieged cannabis industry needs ...

Young adults in the US are choosing cannabis over vaping and cigarettes

Written by Tiziana Cauli | 28th August 2023

Young US adults are more likely to use cannabis than to vape or smoke cigarettes, says a new Gallup poll, and concerns about cannabis use are not comparable to fears around vaping and smoking ...

22nd Century's cannabinoid business accounts for two-thirds of Q2 revenue

Written by Freddie Dawson | 16th August 2023

22nd Century announced a positive second-quarter result for its cannabinoid business, with the division supplying most of its quarterly revenue ...

Cannabis companies shed US assets to focus on more lucrative markets

Written by Lorraine Mullaney | 27th July 2023

Major cannabis firms are streamlining their North American operations and reallocating resources toward markets with what they see as more long-term growth potential ...

Is the cannabis sector failing to ensure gender equality at its own expense?

Written by Tiziana Cauli | 17th July 2023

Women started entering the cannabis sector right at its beginning, and by 2015 over one third of US executives in cannabis companies were female. In 2017 this figure was down to 26% ...

US FDA and FTC join together in warning producers of delta-8 THC ingestibles

Written by Tiziana Cauli | 10th July 2023

The US Federal Trade Commission and Food and Drug Administration have sent warning letters to six sellers of delta-8 THC edibles whose packaging is very similar to that of popular snacks and sweets for children...

Canopy Growth takes stock for fiscal year 2023, looks ahead to new deals and ideas

Written by Freddie Dawson | 26th June 2023

Canopy Growth will stop producing its own cannabis beverages, edibles, vapes and extracts as it continues to look at ways to increase profitability. Using a third-party sourcing model for these products will allow it to...

Minnesota set to join 22 other US states in legalising recreational cannabis

Written by CannIntelligence | 26th May 2023

Legal recreational cannabis sales for adult use are expected to begin next year in Minnesota following agreement on a bill between the state’s House and Senate ...

Value of US industrial hemp harvest drops by more than two-thirds in a year

Written by Tiziana Cauli | 23rd May 2023

Hemp production in the US suffered a major decline last year, with the planted area shrinking by 48% against 2021 and the total value of the harvested crop falling by 71% ...

22nd Century forecasts full-year sales upward of $105m after Q1 records

Written by Antonia Di Lorenzo | 12th May 2023

US-based 22nd Century reported record cannabinoid ingredient volumes delivered in the first quarter of 2023 and expects those to increase further throughout the year ...

Twitter policy on cannabis advertising remains obscure after latest shift

Written by Freddie Dawson | 9th May 2023

Twitter has claimed to have made another “major” step forward in cannabis advertising. But again the devil is in the details, which remain vague and contradictory ...

Cookies teams up with e-cigarette maker to supply CBD vaporisers across the US

Written by Tiziana Cauli | 4th May 2023

California-based e-cigarette manufacturer Ispire Technology has signed a partnership with US cannabis brand Cookies to sell CBD vapes across the United States ...

A year of ups and downs for Canadian producer Rubicon Organics in 2022

Written by Antonia Di Lorenzo | 27th April 2023

Producer Rubicon Organics delivered net revenue of CAD35.5m (USD26.1m) for the year ending 31st December 2022, which represents significant net revenue growth of 57% compared to 2021 ...

Pharmaceutical cannabinoid companies in Canada, US release positive results

Written by Antonia Di Lorenzo | 26th April 2023

Avicanna in Toronto reported total fiscal 2022 revenue up 24% from fiscal 2021, while in Pennsylvania, Zynerba Pharmaceuticals reduced its net loss last year by over $2m ...

Verano Holdings revenue boosted by New Jersey legalisation, new Florida stores

Written by Antonia Di Lorenzo | 24th April 2023

Verano Holdings reported revenue up 19% to $879m in 2022 from $738m in 2021 and said it will continue to strengthen its business portfolio by focusing on targeted expansion and new product launches ...

Has a wording error in a new law just banned hemp in Arkansas?

Written by Anthony Traurig | 20th April 2023

Arkansas may have inadvertently banned hemp with the passage of a bill that was intended to prohibit the production and sale of intoxicating hemp-derived cannabinoid products but went much further ...

LATEST ALERTS